These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 7585774

  • 21. Cardioprotection and ACE inhibitors.
    Ball SG.
    Clin Physiol Biochem; 1992; 9(3):98-104. PubMed ID: 1302164
    [Abstract] [Full Text] [Related]

  • 22. Therapy of left ventricular dysfunction: implications of recent therapeutic trials and future directions for therapy.
    Pitt B.
    Schweiz Med Wochenschr; 1993 Feb 27; 123(8):342-8. PubMed ID: 8095738
    [Abstract] [Full Text] [Related]

  • 23. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S.
    Nat Clin Pract Cardiovasc Med; 2006 Apr 27; 3(4):220-5. PubMed ID: 16568131
    [Abstract] [Full Text] [Related]

  • 24. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R, Papa K, Bernocchi P, Gimbatti OJ, Golcea SS, Bettini A, Ceconi C.
    Ital Heart J; 2005 Nov 27; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [Abstract] [Full Text] [Related]

  • 25. [ACE inhibitors after myocardial infarction: close-up on zofenopril].
    Teyssedou A.
    Ann Cardiol Angeiol (Paris); 2007 Jun 27; 56(3):137-44. PubMed ID: 17482555
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P.
    J Renin Angiotensin Aldosterone Syst; 2000 Mar 27; 1(1):18-20. PubMed ID: 11967789
    [Abstract] [Full Text] [Related]

  • 28. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
    Pfeffer MA.
    Herz; 1993 Dec 27; 18 Suppl 1():430-5. PubMed ID: 8125423
    [Abstract] [Full Text] [Related]

  • 29. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M, Solomon SD.
    Curr Opin Cardiol; 2006 Jul 27; 21(4):268-72. PubMed ID: 16755193
    [Abstract] [Full Text] [Related]

  • 30. ACE inhibitors in heart failure: what more do we need to know?
    Demers C, Mody A, Teo KK, McKelvie RS.
    Am J Cardiovasc Drugs; 2005 Jul 27; 5(6):351-9. PubMed ID: 16259523
    [Abstract] [Full Text] [Related]

  • 31. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
    Ambrosioni E, Borghi C, Magnani B.
    N Engl J Med; 1995 Jan 12; 332(2):80-5. PubMed ID: 7990904
    [Abstract] [Full Text] [Related]

  • 32. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC, Korea Acute Myocardial Infarction Registry Investigators.
    Am Heart J; 2010 Jun 12; 159(6):1012-9. PubMed ID: 20569714
    [Abstract] [Full Text] [Related]

  • 33. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C, Munger MA.
    Ann Pharmacother; 1993 Jun 12; 27(6):755-66. PubMed ID: 8329800
    [Abstract] [Full Text] [Related]

  • 34. [Converting enzyme inhibitors and coronary failure].
    Castaigne A, Saal JP, Albo C, Verschuren P, Pham I.
    Rev Prat; 1992 Dec 15; 42(20):2568-73. PubMed ID: 1299942
    [Abstract] [Full Text] [Related]

  • 35. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A.
    J Am Geriatr Soc; 2002 Jul 15; 50(7):1293-6. PubMed ID: 12133028
    [Abstract] [Full Text] [Related]

  • 36. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.
    Goa KL, Balfour JA, Zuanetti G.
    Drugs; 1996 Oct 15; 52(4):564-88. PubMed ID: 8891468
    [Abstract] [Full Text] [Related]

  • 37. Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers.
    Coletta C, Ricci R, Ceci V, Seccareccia F, Rulli F, Mazzuca V, Putini RL, Salustri A, Bottero G, Pasquale M.
    G Ital Cardiol; 1999 Feb 15; 29(2):115-24; discussion 125-9. PubMed ID: 10088066
    [Abstract] [Full Text] [Related]

  • 38. Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction?
    Ball SG, Hall AS.
    Am Heart J; 1996 Jul 15; 132(1 Pt 2 Su):244-50. PubMed ID: 8677863
    [Abstract] [Full Text] [Related]

  • 39. ACE inhibitors: myocardial infarction and congestive heart failure.
    Cody RJ.
    Am Fam Physician; 1995 Nov 01; 52(6):1801-6. PubMed ID: 7484690
    [Abstract] [Full Text] [Related]

  • 40. [Lisinopril: myocardial infarction, the first 24 hours, in patients with stable hemodynamic status. The GISSI-3 study; results at 6 weeks].
    Tognoni G.
    Arch Mal Coeur Vaiss; 1995 Aug 01; 88 Spec No 3():25-34. PubMed ID: 7503614
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.